Skip to main content
Signal8

DENKHAUS DONALD A

SEC insider (Form 3/4/5 filer). CIK 0001278439. Director at CATALYST PHARMACEUTICALS, INC. (CPRX). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in CORAL GABLES, FL.

Companies DENKHAUS DONALD A has filed insider reports for

  • CATALYST PHARMACEUTICALS, INC. (CPRX): Director
DENKHAUS DONALD A profile photo

DENKHAUS DONALD A

CIK: 0001278439

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)7 (58.3%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (8.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CATALYST PHARMACEUTICALS, INC. logo
CPRX

CATALYST PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Jul 15, 2026
    Disposition
    Direct
    498.8K shares at avg. $31.50$15.7M
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 29, 2025
    Exercise
    Direct
    1.3K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 8, 2025
    Exercise
    Direct
    1.4K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Nov 21, 2025
    Exercise
    Direct
    947 shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Nov 20, 2025
    Award

    Options to purchase common stock

    Direct
    18.1K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Nov 20, 2025
    Award

    Restricted Stock Units

    Direct
    5.5K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Feb 14, 2025
    Exercise
    Direct
    4K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Jan 8, 2025
    Exercise
    Direct
    50K shares at avg. $2.24$112K
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 27, 2024
    Exercise
    Direct
    1.3K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 9, 2024
    Exercise
    Direct
    1.4K shares-

1-10 of 12